A good, short, video overview of Cantab Therapeutics (C.PILL) on Investment Pitch.
Canntab has developed an extended release cannabis delivery system, a hard pill, which allows the dosage of cannabis products to be controlled precisely. It is a patentable technology and critical for the effective medical use of cannabis and cannabinoids in therapeutic settings.
The company has achieved a full-on licencing arrangement with a company in Colombia which will mean that Canntab’s products will be distributed in Colombia and a number of other Spanish speaking markets. As part of this arrangement, Canntab will receive an initial payment of 2 million US dollars. Hard cash for real intellectual property.